Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Dec 01, 2022
Foundation Announces 2022 Grant Recipients
The Doctors Company Foundation has awarded new grants for projects that include risk assessment tools, an OR crisis checklist, and an immersive procedural training platform.
From
The Doctor’s Advocate
The Doctors Company Recognized for Providing Expert Insights and Resources in Changing Healthcare Landscape
The Insurance Marketing and Communications Association (IMCA) recognized The Doctors Company for its exceptional efforts to educate and support healthcare professionals as they navigate the rapidly changing healthcare industry, especially as they adapt to evolving technologies.
Nurse Practitioners, Are You Protecting Your Career? 5 Questions to Ask About Your Professional Liability Insurance
Nurse practitioners face distinct, significant, and long-lasting liability risks, and providing excellent care is not enough to mitigate them. Careful consideration of liability coverage options is essential for midwives to protect their licenses, reputations, professional and geographic mobility, and long-term financial health.
June 25, 2025, Business Insurance
Doctors Aren’t Talking Up Their Career: Survey
According to a recent study conducted by The Doctors Company, only 12 percent of doctors are likely to recommend that people join their profession.
October 05, 2022, Business Insurance
Dobbs Decision Casts Shadow on Med Mal
Robert White, President of The Doctors Company and TDC Group, explains how the U.S. Supreme Court decision to overturn the 50-year-old Roe vs. Wade ruling has created uncertainty for medical providers and medical malpractice insurers.
February 12, 2023, Medical Device & Technology
Urgency Needed for Medical Grade Wearables
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, discusses the importance of understanding how technology like wearables impacts medical liability.
February 28, 2023, Medtech Insight
So the Public Health Emergency Is Over. Now What?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, provides insight about what the official end of the COVID-19 emergency means for average Americans.
April 08, 2022, Medical Economics
COVID-19’s Impact on Malpractice Premiums
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, explains why the COVID-19 pandemic has produced far fewer malpractice claims than originally expected.
Manage Patient Distraction During Telehealth Visits
Distracted patient behaviors during telehealth visits can affect the practitioner’s ability to establish rapport and provide safe, effective patient care.
